IP Library Granted Patent US 9,751,758
Granted Patent B2
US 9,751,758 · App. 14/373,161 · Granted Sep 5, 2017

Rational assembly of nanoparticle superlattices with designed lattice symmetries

Inventors: Oleg Gang (New York, NY); Fang Lu (Miller Place, NY); Miho Tagawa (Nagoya, JP)
Assignee: Brookhaven Science Associates, LLC
B82B3/00C12Q1/68B82Y30/00B82Y40/00Y10S977/84Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,751,758
App. No.
14/373,161
Granted
Sep 5, 2017
Kind
B2
Abstract

A method for lattice design via multivalent linkers (LDML) is disclosed that introduces a rationally designed symmetry of connections between particles in order to achieve control over the morphology of their assembly. The method affords the inclusion of different programmable interactions within one linker that allow an assembly of different types of particles. The designed symmetry of connections is preferably provided utilizing DNA encoding. The linkers may include fabricated “patchy” particles, DNA scaffold constructs and Y-shaped DNA linkers, anisotropic particles, which are preferably functionalized with DNA, multimeric protein-DNA complexes, and particles with finite numbers of DNA linkers.

Claims (18)

1. A controllable nanoparticle superlattice comprising,

a linker comprising a specified symmetry of connecting sites, wherein the linker is a symmetric DNA scaffold construct, an anisotropic particle, a multimeric protein-DNA complex, or a “patchy” particle, and wherein the connecting sites of the linker have non-complementary DNA and/or RNA attached thereto; and

a nanoparticle encapsulated with non-complementary DNA and/or RNA, wherein the non-complementary DNA and/or RNA of the nano particle is complementary to the non-complementary DNA and/or RNA of the linker so as to form a nanoparticle superlattice, wherein the symmetry of the superlattice is determined by the specified symmetry of the connecting sites of the linker.

2. The controllable nanoparticle superlattice according to claim 1 , wherein the linker is a symmetric DNA scaffold construct or an anisotropic particle.

3. The controllable nanoparticle superlattice according to claim 1 , wherein the the linker is a symmetric DNA scaffold construct.

4. The controllable nanoparticle superlattice according to claim 3 , wherein the symmetric DNA scaffold construct has one of a cubic geometry, tetrahedron geometry, or octahedron geometry.

5. The controllable nanoparticle superlattice according to claim 4 , wherein the symmetric DNA scaffold construct is a DNA tetrahedron.

6. The controllable nanoparticle superlattice according to claim 1 , wherein the formed nanoparticle superlattice is a diamond lattice, simple cubic lattice or perovskite lattice.

7. The controllable nanoparticle superlattice according to claim 1 , wherein the anisotropic particle has connecting sites at particle facets.

8. The controllable nanoparticle superlattice according to claim 1 , wherein the anisotropic particle has connecting sites at particle vertices.

9. The controllable nanoparticle superlattice according to claim 1 , wherein the anisotropic particle is metal.

10. The controllable nanoparticle superlattice according to claim 9 , wherein the metal is selected from the group consisting of gold, silver, and platinum.

11. The controllable nanoparticle superlattice according to claim 1 , wherein the linker is an anisotropic particle comprising a semiconductor.

12. The controllable nanoparticle superlattice according to claim 11 , wherein the semiconductor is selected from the group consisting of cadmium selenide, cadmium sulfide, zinc sulfide, and gallium arsenide.

13. The controllable nanoparticle superlattice according to claim 1 , wherein the linker is a magnetic anisotropic particle.

14. The controllable nanoparticle superlattice according to claim 13 , wherein the magnetic anisotropic particle is iron oxide.

15. The controllable nanoparticle superlattice according to claim 1 , wherein the linker is an anisotropic particle comprising silicon dioxide.

16. The controllable nanoparticle superlattice according to claim 1 , wherein the linker is a multimeric protein-DNA complex comprising a knob adenovirus protein or streptavidin tetramer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2016
From: GANG, OLEG; LU, FANG; TAGAWA, MIHO
To: BROOKHAVEN SCIENCE ASSOCIATES, LLC
Reel/Frame 038642/0320 →
CONFIRMATORY LICENSE Recorded Oct 7, 2015
From: BROOKHAVEN SCIENCE ASSOCIATES, LLC
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 036815/0737 →
Continuity (2)
Provisional Application 61587786 · Jan 18, 2012
Related Publication 20150017444A1 · Jan 15, 2015